January 28, 2013 – Samsung Electronics America, Inc. announced its acquisition of NeuroLogica, a leading computed tomography (CT) company headquartered in Danvers, Mass. Established in 2004, NeuroLogica develops cutting-edge medical imaging products and is known for its portable CT scanners, such as BodyTom and CereTom. Terms of the deal were not disclosed.
The acquisition of NeuroLogica is another important step in the expansion of Samsung’s medical imaging business. Samsung will continue to strengthen its capabilities and product portfolio to establish itself as a trusted leader in the health and medical equipment industry. The company only recently entered the U.S. medical imaging market and
The company plans to leverage its global brand awareness and world-leading technology in consumer electronics, IT and communications with NeuroLogica in order to expand medical imaging business.
The UGEO exhibit highlighted ultrasound systems, including premium lines that are soon to be released in the market. Samsung promoted its solidification of premium lines at RSNA 2012 in order to increase its brand awareness in the radiology market after mainly targeting OB/GYN with high-end and mid-range ultrasound systems.
Samsung previously acquired ultrasound systems maker Medison and had previously focused on the OB/GYN ultrasound systems market. At the 2012 Radiological Society of North America (RSNA) meeting in December, Samsung had a major presence on the show floor to raise awareness about its brand and its plans to expand in the U.S. radiology market.
"Our vision is to grow our business worldwide by entering the radiology market in the United States with our high-quality products," said Sang Won Bang, CEO of Samsung Medison and head of the Samsung Electronics Health and Medical Equipment Team. "Samsung will continue to put effort in developing innovative products that offer convenience to both doctors and patients in diverse diagnostic fields."